Search
for

    Sort by

    Research 31–60 of 69

    1. Periungual lesions secondary to chemotherapy with docetaxel Przegląd Dermatologiczny · 2019
    2. Hair Changes due to Drugs Elsevier eBooks · 2018
    3. S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report Surgical Case Reports · 2018
    4. Long-term treatment within a maximum of 96 weeks of tinea unguium with long-pulsed neodymium-doped yttrium aluminum garnet laser Journal of The American Academy of Dermatology · 2015
    5. Subject Index Journal of The American Academy of Dermatology · 2014
    6. Index 2013
    7. Cancer Treatments and Alopecia: A Systematic Review Turkiye Klinikleri Journal of Internal Medicine · 2021 · 2 citations
    8. EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management Oncology and therapy · 2017 · 29 citations
    9. EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines Anti-Cancer Drugs · 2023 · 7 citations
    10. “PRIDE” Complex Indian Journal of Drugs in Dermatology · 2019 · 3 citations
    11. Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management Dermatology research and practice · 2014 · 68 citations
    12. Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin Expert Review of Dermatology · 2008 · 19 citations
    13. Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis Eye · 2025 · 1 citations
    14. Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment Clinical and Translational Science · 2025
    15. Understanding, recognizing, and managing toxicities of targeted anticancer therapies Ca · 2013 · 278 citations
    16. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆ Annals of Oncology · 2020 · 86 citations
    17. Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy Journal of the American Academy of Dermatology · 2018 · 32 citations
    18. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis Pediatric blood & cancer · 2015 · 26 citations
    19. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches Molecular cancer · 2023 · 16 citations
    20. Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management Journal of Clinical Medicine · 2024 · 15 citations
    21. The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus Supportive Care in Cancer · 2023 · 15 citations
    22. Prophylaxis and Management of Skin Toxicities Breast care · 2019 · 15 citations
    23. Questionnaire Modifications and Alternative Scoring Methods of the Dermatology Life Quality Index: A Systematic Review Value in Health · 2021 · 13 citations
    24. Re-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis? 2018 · 13 citations
    25. Management of Dermatologic Toxicities Journal of the National Comprehensive Cancer Network · 2015 · 12 citations
    26. Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One Journal of Medicinal Chemistry · 2022 · 10 citations
    27. An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study Dermatology and therapy · 2022 · 9 citations
    28. Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital Anais Brasileiros de Dermatologia · 2021 · 7 citations
    29. Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor. PubMed · 2016 · 5 citations
    30. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review Frontiers in Oncology · 2024 · 3 citations